Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Psychiatric Quarterly
Erschienen in: Psychiatric Quarterly 4/2020

29.08.2020 | Review Article

Cognitive Behavioural Therapy for Insomnia Monotherapy in Patients with Medical or Psychiatric Comorbidities: a Meta-Analysis of Randomized Controlled Trials

verfasst von: Fu-Chun Zhou, Yuan Yang, Yuan-Yuan Wang, Wen-Wang Rao, Shu-Fang Zhang, Liang-Nan Zeng, Wei Zheng, Chee H. Ng, Gabor S. Ungvari, Ling Zhang, Yu-Tao Xiang

Erschienen in: Psychiatric Quarterly | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

This is a meta-analysis of randomized controlled trials (RCTs) comparing cognitive behaviour therapy for insomnia (CBT-I) monotherapy with active control treatment for insomnia in patients with medical or psychiatric comorbidities. Both international (PubMed, EMBASE, PsycINFO, Cochrane Library) and Chinese (WanFang, and CNKI) databases were systematically searched. The random effects model was used. Thirteen RCTs comparing CBT-I (n = 441) and active controls (n = 412) groups were included. CBT-I group showed significant advantage over active controls at post-treatment assessment in terms of Insomnia Severity Index (ISI; SMD = -0.74), sleep onset latency (SMD = -0.36), wake after sleep onset (SMD = -0.21), sleep quality (SMD = 0.56), Pittsburgh sleep quality index total scores (PSQI; SMD = -0.76) and the total score of dysfunctional beliefs and attitudes about sleep scale (DBAS; SMD = -1.09). Subgroup analyses revealed significant improvement in sleep onset latency in patients with psychiatric disorders (SMD = -0.45), while significant reduction of number of wakeup after sleep onset was found in patients with medical conditions (SMD = -0.31). This meta-analysis found that CBT-I monotherapy had greater efficacy than other active control treatment for insomnia in patients with medical or psychiatric comorbidities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
American Psychiatric Association, Diagnostic and statistical manual of mental disorders (DSM-5®). 2013: American Psychiatric Pub.
2.
Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51(3):229–34.PubMed
3.
Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010;14(1):69–82.PubMed
4.
Vgontzas AN, et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes care, 2009.
5.
Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491–7.PubMedPubMedCentral
6.
Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manag. 2003;25(4):307–18.
7.
Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33(9):1159–64.PubMedPubMedCentral
8.
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1–3):10–9.PubMed
9.
Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation sleep in America survey. J Psychosom Res. 2004;56(5):497–502.PubMed
10.
Sylvia LG, Dupuy JM, Ostacher MJ, Cowperthwait CM, Hay AC, Sachs GS, et al. Sleep disturbance in euthymic bipolar patients. J Psychopharmacol. 2012;26(8):1108–12.PubMed
11.
Ivbijaro G, et al. Preventing suicide, promoting resilience: Is this achievable from a global perspective? Asia Pac Psychiatry, 2019: p. e12371.
12.
Fuller-Thomson E, West KJ, Baiden P. The tide does turn: predictors of remission from suicidal ideation and attempt among Canadians who previously attempted suicide. Psychiatry Res. 2019;274:313–21.PubMed
13.
Zorick F, Walsh J. Evaluation and management of insomnia: an overview. Principles and Practice of Sleep Medicine (3rd ed). Philadelphia: Saunders, 2000: p. 615–623.
14.
Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev. 2000;4(1):5–20.PubMed
15.
Bajaj V et al. A case of zolpidem dependence with extremely high daily doses. Asia Pac Psychiatry., 2019: p. e12356.
16.
Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577–601.PubMed
17.
Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep. 2006;29(11):1398–414.PubMed
18.
Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3):205–14.PubMed
19.
Espie CA, Barrie LM, Forgan GS. Comparative investigation of the psychophysiologic and idiopathic insomnia disorder phenotypes: psychologic characteristics, patients' perspectives, and implications for clinical management. Sleep. 2012;35(3):385–93.PubMedPubMedCentral
20.
Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151(8):1172–80.PubMed
21.
Montgomery P, Dennis JA. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev. 2003;1:CD003161.
22.
Okajima I, Komada Y, Inoue Y. A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms. 2011;9(1):24–34.
23.
Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63(1):79–89.PubMed
24.
van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018;38:3–16.PubMed
25.
Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006;25(1):3–14.PubMed
26.
Koffel EA, Koffel JB, Gehrman PR. A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev. 2015;19:6–16.PubMed
27.
American Academy of Sleep Medicine, Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of sleep medicine report. Sleep, 2006. 29(11): p. 1415–1419.
28.
O'Donnell JF. Insomnia in cancer patients. Clin Cornerstone. 2004;6(1):S6–S14.PubMed
29.
Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev. 2015;23:54–67.PubMed
30.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.PubMedPubMedCentral
31.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC: American Psychiatric Association Press; 1994.
32.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
33.
American Academy of Sleep Medicine. International classification of sleep disorders. Westchester, IL: American Academy of Sleep Medicine; 2005.
34.
American Academy of Sleep Medicine. International classification of sleep disorders–third edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine; 2014.
35.
Higgins, J. and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. 2014.
36.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.PubMed
37.
White A, Ernst E. A systematic review of randomized controlled trials of acupuncture for neck pain. Rheumatology (Oxford, England). 1999;38(2):143–7.
38.
Atkins D, et al. Grading quality of evidence and strength of recommendations. BMJ (Clinical research ed.). 2004;328(7454):1490.
39.
Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.PubMed
40.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMed
41.
Dossing A, Tarp S, Furst DE, Gluud C, Beyene J, Hansen BB, et al. Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol. BMJ Open. 2014;4(9):e005297.PubMedPubMedCentral
42.
Higuchi T, Ishigooka J, Iyo M, Yeh CB, Ebenezer EG, Liang KY, et al. Lurasidone in the treatment of schizophrenia: results of a double-blind, placebo-controlled trial in Asian patients. Asia Pac Psychiatry. 2019;11(2):e12352.PubMed
43.
Wang X, Jiang H, Zhao M, Li J, Gray F, Sheng L, et al. Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: a phase 3 randomized, double-blind, placebo-controlled trial. Asia Pac Psychiatry. 2019;11(1):e12344.PubMed
44.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ: British Medical Journal. 2003;327(7414):557–60.PubMedPubMedCentral
45.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedPubMedCentral
46.
Taylor DJ, et al. Internet and in-person cognitive behavioral therapy for insomnia in military personnel: a randomized clinical trial. Sleep. 2017:40(6).
47.
Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ-British Medical Journal. 2011;343:d4002.
48.
Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Nicassio P, Ganz PA, et al. Tai chi Chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast Cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol. 2017;35(23):2656–65.PubMedPubMedCentral
49.
Garland SN, Rouleau CR, Campbell T, Samuels C, Carlson LE. The comparative impact of mindfulness-based Cancer recovery (MBCR) and cognitive behavior therapy for insomnia (CBT-I) on sleep and mindfulness in cancer patients. Explore (NY). 2015;11(6):445–54.
50.
Martinez MP, et al. Cognitive-behavioral therapy for insomnia and sleep hygiene in fibromyalgia: a randomized controlled trial. J Behav Med. 2014;37(4):683–97.PubMed
51.
Smith MT, Finan PH, Buenaver LF, Robinson M, Haque U, Quain A, et al. Cognitive-behavioral therapy for insomnia in knee osteoarthritis: a randomized, double-blind, active placebo-controlled clinical trial. Arthritis Rheumatol. 2015;67(5):1221–33.PubMedPubMedCentral
52.
Norell-Clarke A, Jansson-Fröjmark M, Tillfors M, Holländare F, Engström I. Group cognitive behavioural therapy for insomnia: effects on sleep and depressive symptomatology in a sample with comorbidity. Behav Res Ther. 2015;74:80–93.PubMed
53.
54.
Harvey AG, Soehner AM, Kaplan KA, Hein K, Lee J, Kanady J, et al. Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol. 2015;83(3):564–77.PubMedPubMedCentral
55.
56.
Sánchez AI, et al. Effects of cognitive-behavioral therapy for insomnia on polisomnographic parameters in fibromyalgia patients. Int J Clin Health Psychol. 2012;12(1):39–53.
57.
Miro E, et al. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: a pilot, randomized controlled trial. J Health Psychol. 2011;16(5):770–82.PubMed
58.
59.
Metadaten
Titel
Cognitive Behavioural Therapy for Insomnia Monotherapy in Patients with Medical or Psychiatric Comorbidities: a Meta-Analysis of Randomized Controlled Trials
verfasst von
Fu-Chun Zhou
Yuan Yang
Yuan-Yuan Wang
Wen-Wang Rao
Shu-Fang Zhang
Liang-Nan Zeng
Wei Zheng
Chee H. Ng
Gabor S. Ungvari
Ling Zhang
Yu-Tao Xiang
Publikationsdatum
29.08.2020
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 4/2020
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-020-09820-8

Weitere Artikel der Ausgabe 4/2020

Psychiatric Quarterly 4/2020 Zur Ausgabe

Review Article

“The COVID-19 Pandemic and its Effect on Mental Health in USA – A Review with Some Coping Strategies”

Review Article

Finding Common Ground for Diverging Policies for Persons with Severe Mental Illness

Review Article

A Systematic Review and Meta-Analysis of Randomized Sham-Controlled Trials of Repetitive Transcranial Magnetic Stimulation for Bipolar Disorder

Original Paper

Sociodemographic Factors and Medication Administration Factors Affecting Re – Hospitalization in Patients with Schizophrenia – Spectrum Disorders

Review Article

A Review of School-Based Interventions to Reduce Stigma towards Schizophrenia

Review Article

The Assaultive Staff Action Program (ASAP): Thirty Year Program Analysis

Neu im Fachgebiet Psychiatrie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise